167 related articles for article (PubMed ID: 33115803)
1. Endocytosis-Mediated Replenishment of Amino Acids Favors Cancer Cell Proliferation and Survival in Chromophobe Renal Cell Carcinoma.
Xiao Y; Rabien A; Buschow R; Amtislavskiy V; Busch J; Kilic E; Villegas SL; Timmermann B; Schütte M; Mielke T; Yaspo ML; Jung K; Meierhofer D
Cancer Res; 2020 Dec; 80(24):5491-5501. PubMed ID: 33115803
[TBL] [Abstract][Full Text] [Related]
2. Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.
Xiao Y; Clima R; Busch J; Rabien A; Kilic E; Villegas SL; Timmermann B; Attimonelli M; Jung K; Meierhofer D
Cancer Res; 2020 Sep; 80(18):3830-3840. PubMed ID: 32694149
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
4. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
5. Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).
Yang Y; Vocke CD; Ricketts CJ; Wei D; Padilla-Nash HM; Lang M; Sourbier C; Killian JK; Boyle SL; Worrell R; Meltzer PS; Ried T; Merino MJ; Metwalli AR; Linehan WM
Genes Chromosomes Cancer; 2017 Oct; 56(10):719-729. PubMed ID: 28736828
[TBL] [Abstract][Full Text] [Related]
6. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
[TBL] [Abstract][Full Text] [Related]
7. VEGF-induced retinal angiogenic signaling is critically dependent on Ca²⁺ signaling by Ca²⁺/calmodulin-dependent protein kinase II.
Banumathi E; O'Connor A; Gurunathan S; Simpson DA; McGeown JG; Curtis TM
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3103-11. PubMed ID: 21310919
[TBL] [Abstract][Full Text] [Related]
8. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma.
Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694
[TBL] [Abstract][Full Text] [Related]
9. Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations.
Mikuteit M; Zschäbitz S; Autenrieth M; Weichert W; Hartmann A; Steffens S; Erlmeier F
Oncology; 2024; 102(6):503-509. PubMed ID: 38043528
[TBL] [Abstract][Full Text] [Related]
10. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma: New genetic and metabolic insights.
Zhang L; Henske EP
Urol Oncol; 2020 Aug; 38(8):678-681. PubMed ID: 32444178
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11.
Zhang L; Hobeika CS; Khabibullin D; Yu D; Filippakis H; Alchoueiry M; Tang Y; Lam HC; Tsvetkov P; Georgiou G; Lamb C; Stone E; Puigserver P; Priolo C; Henske EP
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2122840119. PubMed ID: 35867762
[TBL] [Abstract][Full Text] [Related]
14. Apical adenosine regulates basolateral Ca2+-activated potassium channels in human airway Calu-3 epithelial cells.
Wang D; Sun Y; Zhang W; Huang P
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1443-53. PubMed ID: 18385283
[TBL] [Abstract][Full Text] [Related]
15. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
16. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.
Sun M; Tong P; Kong W; Dong B; Huang Y; Park IY; Zhou L; Liu XD; Ding Z; Zhang X; Bai S; German P; Powell R; Wang Q; Tong X; Tannir NM; Matin SF; Rathmell WK; Fuller GN; McCutcheon IE; Walker CL; Wang J; Jonasch E
Cancer Res; 2017 Oct; 77(19):5313-5326. PubMed ID: 28807937
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
Ahmed EA; Youssif ME
J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
[TBL] [Abstract][Full Text] [Related]
19. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
20. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
Baraban EG; Elias R; Lin MT; Ged Y; Zhu J; Pallavajjala A; Singla N; Lotan TL; Argani P; Eshleman JR; Epstein JI
Mod Pathol; 2024 May; 37(5):100472. PubMed ID: 38492778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]